A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2006
12/20/2006	CN1879769A Chinese medicinal preparation capable of increasing poultry immunity
12/20/2006	CN1879761A A health product for regulating immunity and resisting mutation and method for preparing same
12/20/2006	CN1879659A A propolis soft capsule, its preparation method and technological process
12/20/2006	CN1879658A Application of cantharis in medicament preparation
12/20/2006	CN1879652A Dried material and method for the manufacture thererof
12/20/2006	CN1879636A Application of oligosaccharide in preparation of medicine for treating hyperacute rejection
12/20/2006	CN1879629A Estrogen replacement therapy
12/20/2006	CN1290867C Polysaccharide of echinacea angustifolia
12/20/2006	CN1290862C Spleen polypeptide extract, its preparing process and use
12/20/2006	CN1290859C Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein
12/20/2006	CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof
12/20/2006	CN1290843C Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl]-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
12/20/2006	CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
12/20/2006	CN1290819C 2-aminopropane-1,3-glycol compound, its use as medicine and its synthetic intermediate
12/20/2006	CN1290574C Injection of donkey hide gelatin and its preparation
12/20/2006	CN1290531C Chinese traditional medicine for treating allergic rhinitis
12/20/2006	CN1290522C Application of horseradish extract in preparation of medicine for immunity regulation
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/19/2006	USRE39433 Therapeutic agents as cytokine antagonists and agonists
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006	US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151117 Administering a X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering from allergic conjunctivitis and allergic rhinitis to decrease in histamine release; side effect reduction
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7151090 Methods for enhancing graft survival by modulating heme oxygenase activity
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2159091C Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
12/19/2006	CA2149170C Agent for prevention or alleviation of allergy symptoms
12/19/2006	CA2145064C Improvements in or relating to immune response modification
12/14/2006	WO2006133398A2 In vitro activated donor t-cells to promote transplant engraftment
12/14/2006	WO2006132607A1 Mutant allergen(s)
12/14/2006	WO2006132548A1 Cell implantation to prevent and/or treat autoimmune disease
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006132293A1 Food composition having immunosuppressive effect by coating antigen structure of allergenic protein by polysaccharide modification
12/14/2006	WO2006132204A1 Transcription factor decoy
12/14/2006	WO2006131347A2 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
12/14/2006	WO2006131336A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
12/14/2006	WO2006131186A1 Oxindoles as kinase inhibitors
12/14/2006	WO2006131013A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα
12/14/2006	WO2006109071A3 Vaccine against burkholderia infections
12/14/2006	WO2006108424A3 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
12/14/2006	WO2006101977A3 Pyrimidine compounds and methods of use
12/14/2006	WO2005007116A3 Artificial antigen presenting cell devices
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060281905 Crystallization of IGF-1
12/14/2006	US20060281902 Human signal peptide-containing proteins
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281820 Lfa-1 inhibitors and use thereof
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281726 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006	US20060281072 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy
12/14/2006	US20060280758 Modified vaccinia ankara virus variant
12/14/2006	US20060280756 Novel composition
12/14/2006	US20060280741 Administering the antibody concurrently with an antagonist of IL-1 alpha to treat psoriatic arthritis; arthritis nodosa; seronegative spondylarthropathy, and ulcerative colitis
12/14/2006	US20060280732 To suppress apoptotic pathways by inhibiting cytochrome c-mediated caspase activation; inhibit effects of apoptosis induced by oxidative stress, drugs, cytokines, Fas-ligand, alpha-fetoprotein, used to prevent apoptosis in culturing cells, in organ transplantation, in immunological autoimmune disorder
12/14/2006	US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns
12/14/2006	DE102005026081A1 Extraction of immunologically active polymers, comprises prepurifying and enzymatically releasing the active polymers from mushroom cell walls by different chitinase
12/14/2006	CA2614295A1 Transcription factor decoy
12/14/2006	CA2611646A1 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
12/14/2006	CA2611483A1 Cell implantation to prevent and/or treat autoimmune disease
12/14/2006	CA2611401A1 Oxindoles as kinase inhibitors
12/14/2006	CA2610310A1 Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
12/14/2006	CA2609999A1 Stable and soluble antibodies inhibiting tnfalpha
12/13/2006	EP1731912A2 Peptide selection method
12/13/2006	EP1731531A2 Multiple cytokine-antibody complexes
12/13/2006	EP1731530A1 A kind of fusion protein, gene encoding it, expression method and use thereof
12/13/2006	EP1731522A1 Process for producing flavone c glycoside derivatives
12/13/2006	EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
12/13/2006	EP1731168A1 Antibody drug
12/13/2006	EP1731167A1 Vaccine against hbv and hpv
12/13/2006	EP1731165A1 Allogenic placenta-lysates/BCG-vaccine
12/13/2006	EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development
12/13/2006	EP1731163A2 Treatment of allergic conditions by use of IL 21
12/13/2006	EP1731162A2 Apparatus, method and compositions for the treatment of cancers by ultraphoresis
12/13/2006	EP1731134A1 Functional powders
12/13/2006	EP1730194A2 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
12/13/2006	EP1730190A2 Inhibiting cav3 isoforms and the &25b splice varients for the diagnosis and treatment of cancer
12/13/2006	EP1729803A2 Therapeutic use of anti-cs1 antibodies
12/13/2006	EP1729799A2 Chemically programmable immunity
12/13/2006	EP1420788B1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
12/13/2006	EP1383765B1 Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction
12/13/2006	EP1328252B1 Transdermal pharmaceutical delivery composition
12/13/2006	EP1261712B1 Proteins named fctrx and nucleic acids encoding same
12/13/2006	EP1121151B1 Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies
12/13/2006	EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
12/13/2006	EP1024836B1 Compositions for delivering genes to antigen presenting cells of the skin
12/13/2006	EP0854885B1 Recombinant anti-cd4 antibodies for human therapy
12/13/2006	EP0809695B1 Transcription factor - e2f-5
12/13/2006	EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006	CN1878767A Azole-based kinase inhibitors
12/13/2006	CN1876833A Anti-hiv agent evaluation method

1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1172